• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

427
72
49
48
24

COUNTRY

47
17
5
5
5

PRICE

291
544
1,056
1,488

PUBLISHED

19
136
459
1,488

PRODUCT TYPE

1,450
18
15
5

Central Nervous System

In 2012 major changes might revolutionize the treatment of multiple sclerosis, as Gilenya, the first novel drug in five years, will be joined by three new products: BG-12, Aubagio, and Lemtrada. Recent exciting developments in drug discovery might also enhance the hopes of those fighting against Alzheimer.

Great commercial and scientific opportunities are to be found in similar battles against a range of diseases and neurodegenerative disorders, e.g. Parkinson’s disease, schizophrenia, migraine, insomnia, epilepsy, etc.

A wide selection of industry reports, scientific journals and academic textbooks in this section allow readers to explore every conceivable facet of this industry, such as market trends, industry forecasts, new drugs in development, the latest research & development, patent applications, and licensing strategies.

Key players featured in our publications include Biogen Idec, Sanofi, Genzyme, and many more. Show Less
Read more

PRODUCT TITLE
Spain Central Nervous System Drugs Market Insights - 2015 Spain Central Nervous System Drugs Market Insights - 2015 - Product Thumbnail Image

Spain Central Nervous System Drugs Market Insights - 2015

The latest research Spain Central Nervous System Drugs Market Insights – 2015, provides CNS drugs market analysis, key products, and competitive landscape in Spain. The research includes CNS drugs...

March 2015
FROM
Alzheimer Disease - New Drugs, Markets and Companies Alzheimer Disease - New Drugs, Markets and Companies - Product Thumbnail Image

Alzheimer Disease - New Drugs, Markets and Companies

Alzheimer's disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable...

March 2015
FROM
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies

The delivery of drugs to central nervous system (CNS) is a challenge in the treatment of neurological disorders. Drugs may be administered directly into the CNS or administered systematically (e.g.,...

March 2015
FROM

Encephalomyelitis - Pipeline Review, H1 2015

Encephalomyelitis - Pipeline Review, H1 2015 Summary This, ‘Encephalomyelitis - Pipeline Review, H1 2015’, provides an overview of the Encephalomyelitis’s therapeutic pipeline. This report provides...

February 2015
FROM

Visceral Pain - Pipeline Review, H1 2015

Visceral Pain - Pipeline Review, H1 2015 Summary This ‘Visceral Pain - Pipeline Review, H1 2015’, provides an overview of the Visceral Pain’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Neuromyelitis Optica (Devic's Syndrome) - Pipeline Review, H1 2015

Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2015 Summary This ‘Neuromyelitis Optica (Devic’s Syndrome) - Pipeline Review, H1 2015’, provides an overview of the Neuromyelitis...

February 2015
FROM

Anorexia Nervosa Global Clinical Trials Review, H1, 2015

Anorexia Nervosa Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Anorexia Nervosa Global Clinical Trials Review, H1, 2015" provides data on the Anorexia Nervosa...

February 2015
FROM

Friedreich Ataxia Global Clinical Trials Review, H1, 2015

Friedreich Ataxia Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Friedreich Ataxia Global Clinical Trials Review, H1, 2015" provides data on the Friedreich Ataxia...

February 2015
FROM

Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2015

Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Lennox-Gastaut Syndrome Global Clinical Trials Review, H1, 2015" provides data on the Lennox-Gastaut...

February 2015
FROM

Alcohol Addiction Global Clinical Trials Review, H1, 2015

Alcohol Addiction Global Clinical Trials Review, H1, 2015 Summary This new clinical trial report, “Alcohol Addiction Global Clinical Trials Review, H1, 2015" provides data on the Alcohol Addiction...

February 2015
FROM

Leukodystrophies - Pipeline Review, H1 2015

Leukodystrophies - Pipeline Review, H1 2015 Summary This, ‘Leukodystrophies - Pipeline Review, H1 2015’, provides an overview of the Leukodystrophies’s therapeutic pipeline. This report provides...

February 2015
FROM

Trigeminal Neuralgia - Pipeline Review, H1 2015

Trigeminal Neuralgia - Pipeline Review, H1 2015 Summary This, ‘Trigeminal Neuralgia - Pipeline Review, H1 2015’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline. This report...

February 2015
FROM

Hemiplegia Global Clinical Trials Review, H1, 2015

Hemiplegia Global Clinical Trials Review, H1, 2015 Summary Our clinical trial report, “Hemiplegia Global Clinical Trials Review, H1, 2015" provides data on the Hemiplegia clinical trial scenario....

February 2015
FROM

Batten Disease - Pipeline Review, H1 2015

Batten Disease - Pipeline Review, H1 2015 Summary This, ‘Batten Disease - Pipeline Review, H1 2015’, provides an overview of the Batten Disease’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Chronic Pain - Pipeline Review, H1 2015

Chronic Pain - Pipeline Review, H1 2015 Summary This, ‘Chronic Pain - Pipeline Review, H1 2015’, provides an overview of the Chronic Pain’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Spinal Stenosis - Pipeline Review, H1 2015

Spinal Stenosis - Pipeline Review, H1 2015 Summary This, ‘Spinal Stenosis - Pipeline Review, H1 2015’, provides an overview of the Spinal Stenosis’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Western Equine Encephalitis - Pipeline Review, H1 2015

Western Equine Encephalitis - Pipeline Review, H1 2015 Summary This, ‘Western Equine Encephalitis - Pipeline Review, H1 2015’, provides an overview of the Western Equine Encephalitis’s therapeutic...

February 2015
FROM

Anxiety Disorders - Pipeline Review, H1 2015

Anxiety Disorders - Pipeline Review, H1 2015 Summary This, ‘Anxiety Disorders - Pipeline Review, H1 2015’, provides an overview of the Anxiety Disorders’s therapeutic pipeline. This report provides...

February 2015
FROM

EpiCast Report: Insomnia - Epidemiology Forecast to 2023

EpiCast Report: Insomnia - Epidemiology Forecast to 2023 Summary The publisher epidemiologists forecast that the total prevalent cases of acute insomnia in the 7MM will increase from 121,799,911 total...

February 2015
FROM
Requip IR-Drug Insights,2014 Requip IR-Drug Insights,2014 - Product Thumbnail Image

Requip IR-Drug Insights,2014

“Requip IR - Drug Insights, 2014” provides Requip IR marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed...

February 2015
FROM
Loading Indicator

Our Clients

Shire PLC. GlaxoSmithKline PLC Astrazeneca PLC Roche Diagnostics Ltd. H. Lundbeck A/S Electrical Geodesics, Inc.